Scheme of Amalgamation
13-12-2018: The Scheme of Amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK CH), and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of Companies Act, 2013, approved by the Board of Directors in their meeting held on 3rd December, 2018 has been submitted with National Stock Exchange of India Limited and BSE Limited.
Related Links
- Update on Scheme of Amalgamation - BSEPDF | 164KB (PDF 163KB)
- Update on Scheme of Amalgamation - NSEPDF | 163KB (PDF 162KB)
- NSE Approval of Scheme of ArrangementPDF | 2MB (PDF 1.18MB)
- BSE Approval of Scheme of ArrangementPDF | 2MB (PDF 1.23MB)
- Minutes of the Equity Shareholders MeetingPDF | 557KB (PDF 557KB)
- Minutes of Unsecured Creditors MeetingPDF | 521KB (PDF 521KB)
- Attendance Slip - Unsecured Creditors MeetingPDF | 2MB (PDF 1.82MB)
- Attendance Slip - Equity Shareholders MeetingPDF | 3MB (PDF 2.55MB)
- Notice for Unsecured Creditors MeetingPDF | 5MB (PDF 4.37MB)
- Notice for Equity Shareholders MeetingPDF | 16MB (PDF 15.38MB)
- NCLT Order for conducting MeetingsPDF | 426KB (PDF 426KB)
- Observation Letter - BSEPDF | 166KB (PDF 166KB)
- Observation Letter - NSEPDF | 295KB (PDF 295KB)
- Compliance ReportPDF | 493KB (PDF 492KB)
- Underaking Para 9(a) & (b) of SEBI Circular on Scheme of ArrangementPDF | 749KB (PDF 748KB)
- Auditor CertificatePDF | 1011KB (PDF 1,011KB)
- Financial details of last three years of Transferee Company and Transferor CompanyPDF | 478KB (PDF 477KB)
- Fairness OpinionPDF | 2MB (PDF 1.32MB)
- Audit Committee ReportPDF | 850KB (PDF 850KB)
- Valuation ReportPDF | 371KB (PDF 370KB)
- Draft Scheme of AmalgamationPDF | 731KB (PDF 730KB)
- Pre and Post Shareholding Pattern of the Transferee and Transferor CompanyPDF | 5MB (PDF 4.72MB)